2,333
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Out-of-pocket cost by cancer stage at diagnosis in commercially insured patients in the United States

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 1318-1329 | Received 22 Sep 2022, Accepted 30 Aug 2023, Published online: 31 Oct 2023

Figures & data

Table 1. Out-of-pocket cost in commercially insured patients by cancer type and stage, year 1 post-diagnosis.

Table 2. Out-of-pocket cost in commercially insured patients by cancer type and stage, year 2 post-diagnosis.

Table 3. Out-of-pocket cost in commercially insured patients by cancer type and stage, year 3 post-diagnosis.

Figure 1. Cumulative out-of-pocket cost by stage at diagnosis. (a) Breast cancer; (b) Cervical cancer; (c) Colorectal cancer; (d) Lung cancer; (e) Ovarian cancer; and (f) Prostate cancer.

Figure 1. Cumulative out-of-pocket cost by stage at diagnosis. (a) Breast cancer; (b) Cervical cancer; (c) Colorectal cancer; (d) Lung cancer; (e) Ovarian cancer; and (f) Prostate cancer.
Figure 1. Cumulative out-of-pocket cost by stage at diagnosis. (a) Breast cancer; (b) Cervical cancer; (c) Colorectal cancer; (d) Lung cancer; (e) Ovarian cancer; and (f) Prostate cancer.

Figure 2. Out-of-pocket cost by stage at diagnosis, years 1–3 post-diagnosis. (a) Breast cancer; (b) Cervical cancer; (c) Colorectal cancer; (d) Lung cancer; (e) Ovarian cancer; and (f) Prostate cancer.

Figure 2. Out-of-pocket cost by stage at diagnosis, years 1–3 post-diagnosis. (a) Breast cancer; (b) Cervical cancer; (c) Colorectal cancer; (d) Lung cancer; (e) Ovarian cancer; and (f) Prostate cancer.
Figure 2. Out-of-pocket cost by stage at diagnosis, years 1–3 post-diagnosis. (a) Breast cancer; (b) Cervical cancer; (c) Colorectal cancer; (d) Lung cancer; (e) Ovarian cancer; and (f) Prostate cancer.
Supplemental material

Supplemental Material

Download MS Word (59.8 KB)